Home › Cohorts › Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy.
Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy. PC22F6F435
2 studies · 1,087 curated samples · 1,007 distinct subject identifiers · 1 shared paper. Grouping rule: shared paper, same submitting centre.
Age categories
| adult | 948 |
| elderly | 78 |
| adolescent | 61 |
Countries
| PL | 1,087 |
Health conditions
| allergy_or_atopy Allergy / atopy / asthma | 129 |
| cardiometabolic_other Other cardiometabolic (hypertension | 66 |
| autoimmune_inflammatory Autoimmune / inflammatory (RA | 40 |
| ibs Irritable bowel syndrome | 21 |
| pregnancy_postpartum Pregnancy / postpartum | 6 |
| ibd_unspecified IBD (unspecified) | 4 |
Studies
| study | title | samples | source |
|---|---|---|---|
| PRJNA850529 | Host factors associated with gut mycobiome structure | 923 | gut_all_v1 |
| PRJNA972625 | Changes in gut mycobiome in Polish melanoma patients | 164 | gut_all_v1 |
Shared papers
- Gut Mycobiota Dysbiosis Is Associated with Melanoma and Response to Anti-PD-1 Therapy. — PMID 38315788 · PMC10985481 · doi · studies: PRJNA850529, PRJNA972625